Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art”
Enfermedades infecciosas y microbiologia clinica (English ed.) · 2025
DOI: 10.1016/j.eimce.2025.03.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2025. Verfasst von Marcial Delgado-Fernández und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Enfermedades Infecciosas, Hospital Regional Universitario de Málaga, Spain. Electronic address: med006803@gmail.com. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Plasma, Antibodies, Neutralizing. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Restitution of humoral immunodeficiency is essential to clear SARS-CoV-2. Intravenous unspecific immunoglobulins are expensive and restricted. So recently donated fresh frozen plasma (FFP) could be useful in this scenario but, are all units neutralizing against SARS-CoV-2? We explored this on 52 donations obtained from "Centro de Transfusión, Tejidos y Células de Málaga, Spain", from April to June 2022. Donors status about SARS-CoV-2 previous infection or vaccination was unknown. Neutralizing activity (at dilutions≥1/160) against real Delta (not circulating), BA.2 (dominant circulating variant), BA.5 (irrupting variant), and BQ.1.1 and XBB.1.5 (not circulating yet) was determined. Higher anti-Spike IgG antibodies cut-offs predicted efficacy of FFP. Different cut-offs have been reported in the literature, but all papers have in common that levels over the higher range of quantification can predict neutralizing activity of recently donated FFP against circulating variants of concern, if used early after donation, not requiring clinical data from donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Enfermedades Infecciosas, Hospital Regional Universitario de Málaga, Spain. Electronic address: med006803@gmail.com.
- Servicio de Enfermedades Infecciosas, Hospital Regional Universitario de Málaga, Spain.
- Vircell S.L., Granada, Spain.
- Centro de Transfusión, Tejidos y Células (CTTC), Málaga, Spain.
- Servicio de Microbiología, Hospital Universitario Clínico San Cecilio, Instituto de Investigación IBS, Granada, Ciber de Enfermedades Infecciosas, CIBERINFEC, Spain.
Zitieren
APA
Delgado-Fernández, M., Ruiz-Mesa, J. D., Rojas-González, A., García-Gemar, G. M., Fuentes-López, A., de Salazar-González, A., & García-García, F. (2025). Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art”. Enfermedades infecciosas y microbiologia clinica (English ed.). https://doi.org/10.1016/j.eimce.2025.03.014
Vancouver
Delgado-Fernández M, Ruiz-Mesa JD, Rojas-González A, García-Gemar GM, Fuentes-López A, de Salazar-González A, et al. Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art”. Enfermedades infecciosas y microbiologia clinica (English ed.). 2025. doi:10.1016/j.eimce.2025.03.014
BibTeX
@article{DelgadoFernndez2025,
author = {Delgado-Fernández, Marcial and Ruiz-Mesa, Juan Diego and Rojas-González, Almudena and García-Gemar, Gracia Mar and Fuentes-López, Ana and de Salazar-González, Adolfo and García-García, Federico},
title = {Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art”},
journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
year = {2025},
doi = {10.1016/j.eimce.2025.03.014}
}
EUVIMED